» Articles » PMID: 35014608

ACE2 Pathway Regulates Thermogenesis and Energy Metabolism

Overview
Journal Elife
Specialty Biology
Date 2022 Jan 11
PMID 35014608
Authors
Affiliations
Soon will be listed here.
Abstract

Identification of key regulators of energy homeostasis holds important therapeutic promise for metabolic disorders, such as obesity and diabetes. ACE2 cleaves angiotensin II (Ang II) to generate Ang-(1-7) which acts mainly through the Mas1 receptor. Here, we identify ACE2 pathway as a critical regulator in the maintenance of thermogenesis and energy expenditure. We found that ACE2 is highly expressed in brown adipose tissue (BAT) and that cold stimulation increases ACE2 and Ang-(1-7) levels in BAT and serum. knockout mice () and knockout mice () displayed impaired thermogenesis. Mice transplanted with brown adipose tissue from display metabolic abnormalities consistent with those seen in the and knockout mice. In contrast, impaired thermogenesis of obese diabetic mice and high-fat diet-induced obese mice were ameliorated by overexpression of or continuous infusion of Ang-(1-7). Activation of ACE2 pathway was associated with improvement of metabolic parameters, including blood glucose, lipids, and energy expenditure in multiple animal models. Consistently, ACE2 pathway remarkably enhanced the browning of white adipose tissue. Mechanistically, we showed that ACE2 pathway activated Akt/FoxO1 and PKA pathway, leading to induction of UCP1 and activation of mitochondrial function. Our data propose that adaptive thermogenesis requires regulation of ACE2 pathway and highlight novel potential therapeutic targets for the treatment of metabolic disorders.

Citing Articles

Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in αMUPA Mice and HEK-293 Cells.

Alkhaleq H, Hacker I, Karram T, Hamoud S, Kabala A, Abassi Z Biomedicines. 2024; 12(10).

PMID: 39457635 PMC: 11505258. DOI: 10.3390/biomedicines12102323.


Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways.

de Lima E, Moretti Jr R, Pomini K, Fornari Laurindo L, Sloan K, Sloan L Biology (Basel). 2024; 13(7).

PMID: 39056712 PMC: 11273409. DOI: 10.3390/biology13070519.


Polygenic subtype identified in ACCORD trial displays a favorable type 2 diabetes phenotype in the UKBiobank population.

Hershberger C, Mariam A, Pantalone K, Buse J, Motsinger-Reif A, Rotroff D Hum Genomics. 2024; 18(1):70.

PMID: 38909264 PMC: 11193210. DOI: 10.1186/s40246-024-00639-z.


Angiotensin II participates in mitochondrial thermogenic functions via the activation of glycolysis in chemically induced human brown adipocytes.

Takeda Y, Yoshikawa T, Dai P Sci Rep. 2024; 14(1):10789.

PMID: 38734719 PMC: 11088625. DOI: 10.1038/s41598-024-61774-0.


Untargeted metabolomics uncovers metabolic dysregulation and tissue sensitivity in ACE2 knockout mice.

Zhao L, Yang W, Ji W, Pan Q, Yang J, Cao X Heliyon. 2024; 10(6):e27472.

PMID: 38496880 PMC: 10944221. DOI: 10.1016/j.heliyon.2024.e27472.


References
1.
Lavoie J, Sigmund C . Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system. Endocrinology. 2003; 144(6):2179-83. DOI: 10.1210/en.2003-0150. View

2.
Puigserver P, Wu Z, Park C, Graves R, Wright M, Spiegelman B . A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998; 92(6):829-39. DOI: 10.1016/s0092-8674(00)81410-5. View

3.
Clarke N, Turner A . Angiotensin-converting enzyme 2: the first decade. Int J Hypertens. 2011; 2012:307315. PMC: 3216391. DOI: 10.1155/2012/307315. View

4.
Ortega-Molina A, Efeyan A, Lopez-Guadamillas E, Munoz-Martin M, Gomez-Lopez G, Canamero M . Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 2012; 15(3):382-94. DOI: 10.1016/j.cmet.2012.02.001. View

5.
Liu X, Zheng Z, Zhu X, Meng M, Li L, Shen Y . Brown adipose tissue transplantation improves whole-body energy metabolism. Cell Res. 2013; 23(6):851-4. PMC: 3674396. DOI: 10.1038/cr.2013.64. View